Subcutaneous injection is the fastest-growing NAD+ format, and the reason is arithmetic. It bypasses digestion and first-pass liver metabolism the same way an infusion does, but you do it yourself, at home, in under a minute, at a fraction of clinic pricing.

Who this format is for

People who have decided they want to skip the digestive tract, and who want to do that repeatedly without booking a clinic chair each time. In the United States this is a prescription route, which means an intake, a prescriber review, and a compounding pharmacy.

How the route works

A subcutaneous injection places a small volume into the fatty layer just under the skin — typically the abdomen or thigh — using a short, fine needle. From there the compound absorbs into circulation over a period of minutes to hours.

Two things follow from that. First, nothing passes through the stomach, the intestine or the liver before reaching the bloodstream, so the losses that dominate oral delivery simply do not occur. Second, absorption is slower and gentler than an intravenous push, which is why the acute reactions people report during fast infusions are less of a feature here.

Why it sits between the other two routes

 OralSubcutaneousIV infusion
Bypasses digestionNoYesYes
WhereAnywhereAt homeClinic
Time per doseSecondsAbout a minute Several hours
AccessOver the counterPrescription Prescription + appointment
Relative costLowestMiddleHighest
Needles involvedNoneYes, self-administered Yes, placed for you

What getting access actually involves

Because compounded injectable NAD+ is prescription-only in the US, the process looks like this in most cases:

  1. An intake questionnaire covering your history, current medications and what you are trying to achieve.
  2. A review by a licensed prescriber, who decides whether the route is appropriate for you. This is a real gate, not a formality — people are declined.
  3. Dispensing from a compounding pharmacy, shipped to you with supplies and instructions.
  4. Self-administration on the schedule you were given.
Compounded is not FDA-approved. Compounded medications are prepared for individual patients and are not reviewed by the FDA for safety, effectiveness or quality the way approved drugs are. That is a meaningful distinction and worth understanding before you start, not after.

The honest downsides

  • It is still needles. Some people adapt within a week. Some never do. Know which you are before committing to a multi-month protocol.
  • Technique matters. Site rotation, clean handling and correct storage are not optional, and sloppiness has consequences that a capsule never produces.
  • Injection-site reactions are common. Redness, tenderness or a small lump at the site is the usual complaint.
  • The evidence base is thinner than for oral. Most human research on NAD+ precursors used oral protocols. Injectable NAD+ is widely used and plausibly reasoned, but it is not sitting on the same depth of published data.
  • You are committing to a process. Intake, review, shipping, refills. It is more administration than buying a bottle.

Is it worth it over oral?

It is worth it if you have a specific reason to bypass digestion and you will realistically keep up a process with needles and refills in it. It is not worth it if you are chasing the idea of a stronger version of a capsule, because the thing that most often determines whether a NAD+ routine does anything is not the route — it is whether you are still doing it in six months.

Walk through the oral-versus-IV comparison if you are still weighing the clinical routes against a daily capsule.

Last reviewed: 3 October 2026. Nothing on this page is medical advice. Eligibility is determined by the prescriber reviewing your intake.